hPSC Cryopreservation Medium-Shownin Biotechnology

hPSC Cryopreservation Medium

Cat. No. RP01003

Features：Clear chemical composition; domestic material supply and in-house intellectual property; Facilitated the approval of IND application for multiple iPSC-derived drugs.

Contents	Amount	Cat. No.	Storage
hPSC Cryopreservation Medium	50mL	RP01003	2℃～8℃

Overview
Citation

Shownin hiPSC/hESC Cryopreservation Medium is a ready-to-use clinical-grade/pharmaceutical-grade cryopreservation protection solution with defined chemical composition, serum-free formula, and no animal-derived components. It preserves the undifferentiated state and expansion ability of cells, and greatly reduces the damage caused by ice crystals to cells during cryopreservation, effectively improving cell recovery rate and viability.

Cell morphology and growth

Recovered hiPSCs (P13) preserved in hiPSC/hESC Cryopreservation Medium.

A, B, and C: hiPSCs 1, 2, and 3 days after recovery, respectively. Scale bar: 200μm.

Related products

hPSC-Motor Neuron Differentiation Kit

Rock inhibitor-Blebbistatin

hPSC-MSC Differentiation Kit

NK Amplification Kit

ncTarget hPSC Medium
Establishment of an induced pluripotent stem cell line from a patient with hereditary transthyretin amyloidosis carrying transthyretin (TTR) mutation p.Phe53Val

2020. He Shan, et al. Stem Cell Research(IF 1.5869).

Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation 2020. He Shan , et al. Stem Cell Research(IF 1.5869).

2020. He Shan , et al. Stem Cell Research(IF 1.5869).

Generation of an induced pluripotent stem cell (iPSC) line (THSJTUi001-A) from a Wilson's disease patient harboring a homozygous Arg778Leu mutation in ATP7B gene 2020. Wang, Shu Hong , et al. Stem Cell Research(IF 1.5869).

2020. Wang, Shu Hong , et al. Stem Cell Research(IF 1.5869).